“As a leading tumor specimen provider, Bio-Options required an accurate solution for classifying tumors. Classifying tumors is a tedious, time-consuming process that ties up our highly trained professionals.
We tried mainstream AI models like GPT-4 and Gemini Pro but they fell short and privacy is critical. This is where InteliGems Labs stepped in. Their Launchpad process and AI models quickly advanced us from concept to a pilot customized to our needs.
The results are amazing: $400,000 in annual savings, 80% faster order fulfillment, and a 20% increase in orders. We're excited to explore further AI innovations with InteliGems; they’re an exceptional AI partner.”
Larry Blocher, M.D., J.D.
CEO, Bio-Options
"We at Harmony are building an AI platform that will provide businesses with the insights they need to make informed decisions and fulfill their fiduciary duty.
We tried commercial LLMs such as GPT-4 and Gemini Pro, but they proved inadequate as zero-hallucination, in-line source citation and accuracy were critical to us.
Harmony partnered with Inteligems Labs to build a bespoke Harmony Odyssey. The InteliGems Labs team undertook a series of R&D activities to invent new algorithms and ML designs to solve data extraction, augmentation and retrieval challenges at scale.
I am confident that the state-of-the-art new technology resulting from the R&D will enable Harmony to deliver 10x value to our clients."
Leticia Lazaridis Goldberg
COO, Harmony Analytics
